Cargando…
Profiling of in vivo, in vitro and reactive zorifertinib metabolites using liquid chromatography ion trap mass spectrometry
Zorifertinib (AZD-3759; ZFB) is a potent, novel, oral, small molecule used for the treatment of non-small cell lung cancer (NSCLC). ZFB is Epidermal Growth Factor Receptor (EGFR) inhibitor that is characterized by good permeability of the blood–brain barrier for (NSCLC) patients with EGFR mutations....
Autores principales: | Al-Shakliah, Nasser S., Kadi, Adnan A., Aljohar, Haya I., AlRabiah, Haitham, Attwa, Mohamed W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301632/ https://www.ncbi.nlm.nih.gov/pubmed/35919181 http://dx.doi.org/10.1039/d2ra02848d |
Ejemplares similares
-
Identification and characterization of in silico, in vivo, in vitro, and reactive metabolites of infigratinib using LC-ITMS: bioactivation pathway elucidation and in silico toxicity studies of its metabolites
por: Al-Shakliah, Nasser S., et al.
Publicado: (2020) -
Reactive intermediates in naquotinib metabolism identified by liquid chromatography-tandem mass spectrometry: phase I metabolic profiling
por: Attwa, Mohamed W., et al.
Publicado: (2019) -
A New Validated HPLC-MS/MS Method for Quantification and Pharmacokinetic Evaluation of Dovitinib, a Multi-Kinase Inhibitor, in Mouse Plasma
por: AlRabiah, Haitham, et al.
Publicado: (2020) -
In Vitro Identification of Potential
Metabolites of Plinabulin (NPI 2358) in Hepatic Preparations Using
Liquid Chromatography–Ion Trap Mass Spectrometry
por: Al-Shakliah, Nasser S., et al.
Publicado: (2022) -
Liquid chromatography–tandem mass spectrometry metabolic profiling of nazartinib reveals the formation of unexpected reactive metabolites
por: Abdelhameed, Ali S., et al.
Publicado: (2019)